Apellis Pharmaceuticals (APLS) Earnings Date, Estimates & Call Transcripts → Biden replacement revealed? (From Paradigm Press) (Ad) Free apls Stock Alerts $49.93 +1.21 (+2.48%) (As of 04/24/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 7Before Market OpensConfirmedActual EPS (Feb. 27) -$0.73 Consensus EPS (Feb. 27) -$0.73 Read Call TranscriptListen to Call Get Apellis Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for APLS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAPLS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.APLS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Schaeffer’s ResearchJust Released: Insider's Secret to Trading OptionsThis Surprisingly Simple Formula Can Double Your Money Collecting Consistent Profits From The Stock Market Is More Accessible Than You Think A small group of individuals are using a legitimate yet rarely discussed strategy to generate income from the stock market. They're NOT day traders. And they're NOT Wall Street suits either. I'm talking about normal "working stiffs" and retirees generating steady income from a source that 99% of investors completely overlook. This overlooked income source can be yours today.Yes! Show Me This Strategy Apellis Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($0.83)($0.56)($0.68)Q2 20243($0.60)($0.41)($0.50)Q3 20243($0.49)($0.29)($0.37)Q4 20243($0.27)($0.15)($0.19)FY 202412($2.19)($1.41)($1.74)Q1 20251$0.06$0.06$0.06Q2 20251$0.23$0.23$0.23Q3 20251$0.30$0.30$0.30Q4 20251$0.45$0.45$0.45FY 20254$1.04$1.04$1.04Q1 20261$1.14$1.14$1.14APLS Earnings Date and InformationApellis Pharmaceuticals last issued its earnings results on February 27th, 2024. The reported ($0.73) EPS for the quarter, hitting the consensus estimate of ($0.73). The firm earned $146.38 million during the quarter, compared to the consensus estimate of $143.34 million. Its quarterly revenue was up 545.9% compared to the same quarter last year. Apellis Pharmaceuticals has generated ($4.48) earnings per share over the last year (($4.48) diluted earnings per share). Earnings for Apellis Pharmaceuticals are expected to grow in the coming year, from ($1.33) to $1.08 per share. Apellis Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Tuesday, May 7th, 2024. Apellis Pharmaceuticals will be holding an earnings conference call on Tuesday, May 7th at 8:30 AM Eastern. Interested parties can register for or listen to the call.. Read More Apellis Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/7/2024Confirmed)------- 2/27/2024Q4 2023($0.73)($0.73)-($0.73)$143.34 million$146.38 million 11/1/2023Q3 2023($0.88)($1.17)($0.29)($1.17)$99.05 million$110.40 million 7/31/2023Q2 2023($1.35)($1.02)+$0.33($1.02)$70.38 million$95.00 million 5/4/2023Q1 2023($1.42)($1.56)($0.14)($1.56)$26.10 million$44.80 million 2/21/2023Q4 2022($1.45)($1.50)($0.05)($1.50)$24.44 million$22.70 million11/7/2022Q3 2022($1.48)($1.75)($0.27)($1.75)$19.82 million$22.06 million Get the Latest News and Ratings for APLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Apellis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022Q2 2022($1.43)($1.46)($0.03)($1.46)$17.16 million$16.32 million 5/4/2022Q1 2022($1.36)($1.42)($0.06)($1.42)$12.81 million$14.38 million 2/28/2022Q4 2021($1.32)($1.61)($0.29)($1.61)$8.52 million$60.29 million 11/8/2021Q3 2021($1.73)($2.28)($0.55)($2.28)$2.32 million$5.65 million 8/8/2021Q2 2021($1.70)($2.72)($1.02)($2.72)$2.26 million$0.62 million 4/27/2021Q1 2021($1.69)($2.32)($0.63)($2.32)-- Apellis Pharmaceuticals Earnings - Frequently Asked Questions When is Apellis Pharmaceuticals's earnings date? Apellis Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Tuesday, May 7th, 2024. Learn more on APLS's earnings history. Did Apellis Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Apellis Pharmaceuticals (NASDAQ:APLS) reported ($0.73) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.73). Learn more on analysts' earnings estimate vs. APLS's actual earnings. How can I listen to Apellis Pharmaceuticals's earnings conference call? The conference call for Apellis Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Apellis Pharmaceuticals's conference call transcript? The conference call transcript for Apellis Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Apellis Pharmaceuticals generate each year? Apellis Pharmaceuticals (NASDAQ:APLS) has a recorded annual revenue of $396.59 million. How much profit does Apellis Pharmaceuticals generate each year? Apellis Pharmaceuticals (NASDAQ:APLS) has a recorded net income of -$528.63 million. APLS has generated -$4.48 earnings per share over the last four quarters. What is Apellis Pharmaceuticals's EPS forecast for next year? Apellis Pharmaceuticals's earnings are expected to grow from ($1.33) per share to $1.08 per share in the next year. More Earnings Resources from MarketBeat Related Companies: IONS Earnings ELAN Earnings JAZZ Earnings CYTK Earnings BPMC Earnings VKTX Earnings CERE Earnings ITCI Earnings MDGL Earnings OGN Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:APLS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apellis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
